Cardiac unloading models for myocardial reverse remodeling.
Source: PubMed, NCBI / U.S. National Library of Medicine
Myocardial reverse remodeling (RR) represents the structural, functional, cellular, and molecular recovery of the failing heart, leading to long-term prognostic improvements. This process can be mediated by various clinical modalities, including pharmacological treatment and interventional/surgical procedures. Among these approaches, left ventricular assist devices (LVADs) exhibit the most potent capacity for mechanical unloading and inducing RR, which has profoundly transformed the treatment paradigm and prognosis of end-stage heart failure. Furthermore, the implantation and explantation of LVAD devices facilitate the collection of paired patient samples before and after treatment, providing a unique real-world model for investigating this phenomenon. However, the scarcity of human myocardial samples is insufficient to meet the demands of elucidating the mechanisms of reverse cardiac remodeling and identifying novel therapeutic targets. Findings derived from human specimens require validation through experimental unloading models, which inherently offer novel perspectives on cardiac pathophysiology. Thus, reproducible models of myocardial unloading have become valuable complementary resources. This review systematically summarizes progress in understanding the relationship between mechanical load and myocardial phenotypes within various unloading models. We further discuss how these reproducible unloading models provide a solid foundation for elucidating the mechan
Abstract
Myocardial reverse remodeling (RR) represents the structural, functional, cellular, and molecular recovery of the failing heart, leading to long-term prognostic improvements. This process can be mediated by various clinical modalities, including pharmacological treatment and interventional/surgical procedures. Among these approaches, left ventricular assist devices (LVADs) exhibit the most potent capacity for mechanical unloading and inducing RR, which has profoundly transformed the treatment paradigm and prognosis of end-stage heart failure. Furthermore, the implantation and explantation of LVAD devices facilitate the collection of paired patient samples before and after treatment, providing a unique real-world model for investigating this phenomenon. However, the scarcity of human myocardial samples is insufficient to meet the demands of elucidating the mechanisms of reverse cardiac remodeling and identifying novel therapeutic targets. Findings derived from human specimens require validation through experimental unloading models, which inherently offer novel perspectives on cardiac pathophysiology. Thus, reproducible models of myocardial unloading have become valuable complementary resources. This review systematically summarizes progress in understanding the relationship between mechanical load and myocardial phenotypes within various unloading models. We further discuss how these reproducible unloading models provide a solid foundation for elucidating the mechanisms of RR and ultimately developing novel therapies to improve patient outcomes.